Selumetinib-d7
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for complete information.
Selumetinib-d7 Product Information
Selumetinib-d7 is listed under Stable Isotopes and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Selumetinib. The product is supplied by Clearsynth under CAT No. CS-T-103544.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Selumetinib-d7
CAS No.
2364350-71-8
CAT No.
CS-T-103544
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C17H8D7BrClFN4O3
Molecular Weight
464.7
Category
API Family
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for complete information.
Description
Regulatory Description
Selumetinib-d7 is supplied with detailed characterization data compliant with regulatory guideline. Selumetinib-d7 can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Selumetinib.
Overview
Selumetinib-D7 is an isotopic labelled compound of Selumetinib (S254000), a tight-binding, uncompetitive inhibitor of mitogen-activated protein kinase kinases (MEK) 1 and 2 currently in clinical development. It is useful as biomarker in human lung cancer cell. Potent MEK inhibitor.
Synonyms
Selumetinib-d7
Application Notes
Selumetinib-D7 is an isotopic labelled compound of Selumetinib (S254000), a tight-binding, uncompetitive inhibitor of mitogen-activated protein kinase kinases (MEK) 1 and 2 currently in clinical development. It is useful as biomarker in human lung cancer cell. Potent MEK inhibitor.
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.